Hemispherx BioPharma Inc. (HEB) Fell -8.3% or -0.04 To Price $0.41 On Wednesday


Hemispherx BioPharma Inc. (HEB) fell -8.3% or -0.04 to $0.41. It is around 110487 shares traded, which is 22.76% compare to the average total volume 485484. The market cap of HEB is $13.07 million. The year to date change is 29.62%. The 52 week price range is from $0.3 to $0.84. Price of HEB have changed 5.22% during last week. It have changed -9.66% over last month, 27.77% over last 3 months, 39.75% over last 6 months and -16.41% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HEB is 0.48. It is 17.07% above current price. The 200-day Moving Averages for HEB is 0.41. The 52-week High is 0.84. It is 104.88% from the current price. The 52-week Low is 0.3. It is -26.83% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HEB is 2.55 on 2018-03-15. Short % to float is 3.95%. There are some statistics of HEB. It is has market cap $13.07 million. The share outstanding is 31.87 million. The average volume is 485484. The percent of top 15 Institution holding is 8.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HEB is -55.90%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HEB is -41.07%.


Tags:

Share this post